PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18923901-5	2009	Simultaneously, celecoxib resulted in significant reduction of Bcl-2 and significant increase of p21(WAF1) and p27(KIP1) in SAC and NC cells.	Celecoxib	16-25	zinc ribbon domain containing 2	Homo sapiens	111-114	
14973068-6	2004	Furthermore, the COX-2 inhibitor celecoxib induced a dose-dependent inhibition of cell growth, cell cycle arrest at the G(1)-S checkpoint, and induction of cyclin-dependent kinase inhibitors p21(waf1/cip1) and p27(kip1).	Celecoxib	33-42	zinc ribbon domain containing 2	Homo sapiens	210-213	
18923901-6	2009	The present study shows that celecoxib causes growth inhibition of gastric carcinoma cells by decreasing Bcl-2 of cyclooxygenase-2-dependent pathway, and by increasing p21(WAF1) and p27(KIP1) of cyclooxygenase-2-independent pathway.	Celecoxib	29-38	zinc ribbon domain containing 2	Homo sapiens	182-185	
18172863-7	2008	Our results further demonstrated that the combinational effects of atorvastatin/celecoxib were associated with increased levels of p21(Cip1/Waf1), p27(Kip1), and phospho-JNK; decreased levels of phospho-AKT and hyper-phosphorylated Rb; and activation of caspase cascade.	Celecoxib	80-89	zinc ribbon domain containing 2	Homo sapiens	147-150